State programs also are focused on expanding benefits and addressing social determinants of health.

First Lady Jill Biden, who will lead the new initiative that will explore public-private partnerships and engage private and philanthropic leaders to drive innovation in women's health, says a lack of research is "not acceptable."

New report suggests the technology eventually will help identify people at risk for chronic diseases and lead to earlier treatment.

Despite increased demand for EWA, misconceptions and underutilization persist among employers and employees.

Tirzepatide, the active ingredient in Lilly's new drug, is already approved under the trade name Mounjaro, a diabetes drug, but Zepbound will list for a lower pre-insurance price than Novo Nordisk's weight loss drug, Wegovy.

New survey from FinanceBuzz.com sheds light on the state-of-mind of remote or hybrid workers.

Nearly half (47%) of all adults look forward to each day, compared to 43% last year.

Incentives for alternative payment models, which Congress created in 2015 to help providers move into new payment models that encourage high quality, cost-effective care, will expire Dec. 31 unless lawmakers extend it.